CORGENIX TERMINATES ITS PROPOSED MERGER WITH GENESIS BIOVENTURES

Corgenix Medical, due to the lack of progress toward the completion of the $6 million merger-related financing and the expiration of key dates within the agreement and plan of merger, decided to terminate the planned merger with Genesis Bioventures.

Pharmabiz.com (http://www.pharmabiz.com/article/detnews.asp?articleid=25725§ionid=)